The acquisition of Pronova BioPharma in January 2013, of Equateq, today BASF Pharma (Callanish), in May 2012 and of Cognis in December 2010 has made BASF a global market leader for omega-3 fatty acids. The newly created portfolio now covers the full range from low to medium to high-concentrate omega-3 fatty acids – for pharmaceuticals, dietary supplements and clinical nutrition. Additionally BASF's offer includes high quality Omega-3 powders for food and infant nutrition applications. Besides its broad portfolio, BASF offers global customer reach, solid know-how and scientific expertise in the production of omega-3 fatty acids.
The Omega-3 Verbund has four production facilities in Norway, Denmark and Scotland and the headquarters in Lilleaker (Oslo), Norway.